BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 8740003)

  • 1. Analysis for recovery and loss of mononuclear cells and colony-forming units granulocyte-macrophage during ex vivo processing of autologous bone marrow.
    Schwella N; Heuft HG; Rick O; Blasczyk R; Wittmann G; Huhn D
    Vox Sang; 1996; 70(3):132-8. PubMed ID: 8740003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of autologous bone marrow grafts for cryopreservation using the AS104 cell separator.
    Rick O; Heuft HG; Wittmann G; Blasczyk R; Huhn D; Schwella N
    J Clin Apher; 1997; 12(4):179-82. PubMed ID: 9483179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: value of the colony-forming unit granulocyte-macrophage (CFU-GM) assay.
    al-Fiar F; Prince HM; Imrie K; Stewart AK; Crump M; Keating A
    Cell Transplant; 1997; 6(5):491-5. PubMed ID: 9331500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
    Smith RJ; Sweetenham JW
    Exp Hematol; 1995 Dec; 23(14):1581-8. PubMed ID: 8542950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow.
    Rowley SD; Zuehlsdorf M; Braine HG; Colvin OM; Davis J; Jones RJ; Saral R; Sensenbrenner LL; Yeager A; Santos GW
    Blood; 1987 Jul; 70(1):271-5. PubMed ID: 3297203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size.
    van der Wall E; Richel DJ; Holtkamp MJ; Slaper-Cortenbach IC; van der Schoot CE; Dalesio O; Nooijen WJ; Schornagel JH; Rodenhuis S
    Ann Oncol; 1994 Nov; 5(9):795-802. PubMed ID: 7531486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y; Harada M; Teshima T; Makino S; Inaba S; Akashi K; Shibuya T; Niho Y
    Exp Hematol; 1995 Jan; 23(1):8-13. PubMed ID: 7527786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
    Douay L; Gorin NC; Mary JY; Lemarie E; Lopez M; Najman A; Stachowiak J; Giarratana MC; Baillou C; Salmon C
    Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures.
    Koller MR; Emerson SG; Palsson BO
    Blood; 1993 Jul; 82(2):378-84. PubMed ID: 8329697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of mononuclear bone marrow cells using the Cobe 2997 blood cell separator.
    Faradji A; Andreu G; Pillier-Loriette C; Bohbot A; Nicod A; Autran B; Bergerat JP; Rio B; Leblond V; Binet JL
    Vox Sang; 1988; 55(3):133-8. PubMed ID: 3070937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
    Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
    Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
    Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support.
    Benjamin RJ; Linsley L; Axelrod JD; Churchill WH; Sieff C; Shulman LN; Elias A; Ayash L; Malachowski ME; Uhl L
    Transfusion; 1995 Oct; 35(10):837-44. PubMed ID: 7570914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-monocyte colony forming unit content of autologous bone marrow transplants in patients with haematological malignancy.
    Petrovecki M; Nemet D; Kolevska T; Marusić M
    Eur J Clin Chem Clin Biochem; 1995 Oct; 33(10):687-91. PubMed ID: 8608188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
    Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
    Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation.
    Rowley SD; Bensinger WI; Gooley TA; Buckner CD
    Blood; 1994 May; 83(9):2731-6. PubMed ID: 7513212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.